Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp., and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria.
Main Authors: | , , |
---|---|
Format: | article biblioteca |
Language: | eng |
Published: |
Frontiers
|
Subjects: | L73 - Maladies des animaux, Bacteria, bactérie gram négatif, Résistance aux antibiotiques, polymyxine, lipopolysaccharide, Enterobacteriaceae, Bacillus, mutation, http://aims.fao.org/aos/agrovoc/c_765, http://aims.fao.org/aos/agrovoc/c_3352, http://aims.fao.org/aos/agrovoc/c_8848, http://aims.fao.org/aos/agrovoc/c_29694, http://aims.fao.org/aos/agrovoc/c_24045, http://aims.fao.org/aos/agrovoc/c_2580, http://aims.fao.org/aos/agrovoc/c_760, http://aims.fao.org/aos/agrovoc/c_5014, |
Online Access: | http://agritrop.cirad.fr/578563/ http://agritrop.cirad.fr/578563/1/fmicb-05-00643.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-cirad-fr-578563 |
---|---|
record_format |
koha |
spelling |
dig-cirad-fr-5785632025-01-07T14:26:28Z http://agritrop.cirad.fr/578563/ http://agritrop.cirad.fr/578563/ Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Olaitan Abiola Olumuyiwa, Morand Serge, Rolain Jean-Marc. 2014. Frontiers in Microbiology, 5 (643), 18 p.https://doi.org/10.3389/fmicb.2014.00643 <https://doi.org/10.3389/fmicb.2014.00643> Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria Olaitan, Abiola Olumuyiwa Morand, Serge Rolain, Jean-Marc eng 2014 Frontiers Frontiers in Microbiology L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp., and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria. article info:eu-repo/semantics/article Journal Article info:eu-repo/semantics/publishedVersion http://agritrop.cirad.fr/578563/1/fmicb-05-00643.pdf text cc_by info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/4.0/ https://doi.org/10.3389/fmicb.2014.00643 10.3389/fmicb.2014.00643 info:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2014.00643 info:eu-repo/semantics/altIdentifier/purl/https://doi.org/10.3389/fmicb.2014.00643 |
institution |
CIRAD FR |
collection |
DSpace |
country |
Francia |
countrycode |
FR |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-cirad-fr |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
Biblioteca del CIRAD Francia |
language |
eng |
topic |
L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 |
spellingShingle |
L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 Olaitan, Abiola Olumuyiwa Morand, Serge Rolain, Jean-Marc Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
description |
Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp., and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria. |
format |
article |
topic_facet |
L73 - Maladies des animaux Bacteria bactérie gram négatif Résistance aux antibiotiques polymyxine lipopolysaccharide Enterobacteriaceae Bacillus mutation http://aims.fao.org/aos/agrovoc/c_765 http://aims.fao.org/aos/agrovoc/c_3352 http://aims.fao.org/aos/agrovoc/c_8848 http://aims.fao.org/aos/agrovoc/c_29694 http://aims.fao.org/aos/agrovoc/c_24045 http://aims.fao.org/aos/agrovoc/c_2580 http://aims.fao.org/aos/agrovoc/c_760 http://aims.fao.org/aos/agrovoc/c_5014 |
author |
Olaitan, Abiola Olumuyiwa Morand, Serge Rolain, Jean-Marc |
author_facet |
Olaitan, Abiola Olumuyiwa Morand, Serge Rolain, Jean-Marc |
author_sort |
Olaitan, Abiola Olumuyiwa |
title |
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
title_short |
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
title_full |
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
title_fullStr |
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
title_full_unstemmed |
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
title_sort |
mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria |
publisher |
Frontiers |
url |
http://agritrop.cirad.fr/578563/ http://agritrop.cirad.fr/578563/1/fmicb-05-00643.pdf |
work_keys_str_mv |
AT olaitanabiolaolumuyiwa mechanismsofpolymyxinresistanceacquiredandintrinsicresistanceinbacteria AT morandserge mechanismsofpolymyxinresistanceacquiredandintrinsicresistanceinbacteria AT rolainjeanmarc mechanismsofpolymyxinresistanceacquiredandintrinsicresistanceinbacteria |
_version_ |
1822258037353611264 |